RxDoctor Payments Data

Mohammed Shaikh, MD

Pain Medicine · Grapevine, TXNPI 1952696635

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,640 of the $13,980 with a category attached, or 69.0%. 42 manufacturers reported payments, led by Abbott at 27.1% of the total. Reporting peaked in 2022 at $3,639 and has fallen 67.2% since, to $1,192 in 2025.

$13,980in general payments, 2019–2025

Across 347 payments — averaging $40.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$3K
  • Painteq LLC$2K
  • Boston Scientific$1K
  • Foundation Fusion Solutions, LLC$907
  • Collegium Pharmaceutical, Inc.$437
  • plus $3K from 36 others
$1,000in research payments, 2019–2025

Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Foundation Fusion Solutions, LLC$1K
$74,737in ownership & investment interests, 2019–2025

Across 5 payments — averaging $14,947 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Simplicity, LLC$75K

What the payments were for

  • Travel & lodging$2,97621%
  • Food & beverage$9,64069%
  • Education$1,3179%
  • Entertainment$470%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,980 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$194,118
Medicare patients
278
Services billed
17,873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen746$21,495
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen269$10,162
OxycontinOxycodone Hcl12$3,895
Pregabalin156$2,782
Gabapentin70$924
Acetaminophen-CodeineAcetaminophen With Codeine35$739
Tramadol Hcl59$630
Morphine Sulfate ErMorphine Sulfate19$553
Methadone Hcl12$423
Morphine Sulfate12$315
Methocarbamol16$313
Oxycodone Hcl17$259
Tizanidine Hcl16$217
Duloxetine Hcl13$204
Cephalexin27$184

Paid to pharmacies, not to this prescriber.

Other pain medicine in Grapevine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →